Adaptive Biotechnologies Corp (NASDAQ:ADPT) traded at $8.33 at close of the session on Friday, February 14 and made a downward move of -2.23% on its previous day’s price.
Looking at the stock we see that its previous close was $8.52 and the beta (5Y monthly) reads 1.495 with the day’s price range being $8.185 – $8.74. In terms of its 52-week price range, ADPT has a high of $8.56 and a low of $2.28. The company’s stock has gained about 16.34% over that past 30 days.
Adaptive Biotechnologies Corp has a market cap of $1.23 billion and is expected to release its quarterly earnings report in March.
On the other hand, looking at the outlook for the ADPT stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Based on estimates by 11 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 6 have rated the Adaptive Biotechnologies Corp (ADPT) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 1 suggest the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 6.72% off its SMA20 and 19.20% from its 50-day simple moving average. The RSI (14) is pointing at 60.62 while the volatility over the past week is 9.45% and jumps to 8.25% over the past one month. The beta value is 1.55, while the average true range (ATR) is currently pointing at 0.63. The average price target for the stock over the next 12 months is $14, with the estimates having a low of $5 and a high of $18. These price ends are 39.98% and -116.09% off the current price level respectively, although investors could be excited at the prospect of a -68.07% if the ADPT share price touches on the median price of $14.
Coming back to Adaptive Biotechnologies Corp (NASDAQ:ADPT), we note that the average 3-month trading volume was 1.42 million, while that of the preceding 10-day period stands at 1.65 million. Current shares outstanding are 147.77 million.
The insiders hold 3.30% of the company’s shares while institutions hold 97.90%. The data shows that short shares as of 2025-01-31, stood at 8.53 million at a short ratio of 5.77. This represents a 742.00 short interest in shares outstanding on 2025-01-31. Shares short fall in January from the previous month at 9.19 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 38.95% up in year-to-date price movement.
